GLYCINOROM 40MG TAB 10 S

About

GLYCINOROM 40MG TAB contains Gliclazide 40mg, an immediate-release sulfonylurea medication used for the treatment of type 2 diabetes mellitus. Gliclazide works by stimulating the beta cells in the pancreas to release insulin, particularly when blood glucose levels are high. This action helps to lower blood sugar. It achieves this by binding to specific receptors on the pancreatic beta cells, leading to a cascade of events that result in the exocytosis of insulin granules. The immediate-release formulation provides a rapid onset of action, typically taken with meals to manage post-prandial glucose excursions.

This medication is indicated for adults with type 2 diabetes when diet, exercise, and weight reduction alone are insufficient to achieve adequate glycemic control. It is crucial for patients to adhere to their prescribed diet and exercise regimen while on Gliclazide to optimize its effects and minimize the risk of hypoglycemia, which is a common and potentially serious side effect of sulfonylureas. Regular monitoring of blood glucose levels is essential to guide therapy.

Uses

• Treatment of type 2 diabetes mellitus
• Reduction of elevated blood glucose
• Stimulation of pancreatic insulin release
• Adjunct to dietary management and exercise

Directions For Use

Take one tablet orally once or twice daily with meals, as directed by your physician. Swallow the tablet whole with water.

Benefits

• Effectively lowers blood glucose levels
• Helps reduce HbA1c
• Improves pancreatic beta-cell response
• Rapid onset of action
• Well-established in diabetes management
• Contributes to better glycemic control

Side Effects

• Hypoglycemia (low blood sugar)
• Weight gain
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Skin rash
• Pruritus (itching)
• Urticaria (hives)
• Photosensitivity (rare)

Safety Measures

• Alcohol - Avoid alcohol consumption as it can significantly increase the risk of hypoglycemia and may cause a disulfiram-like reaction.
• Pregnancy - Not recommended during pregnancy. Insulin is generally the preferred treatment for diabetes in pregnant women.
• Breastfeeding - Not recommended during breastfeeding due to the potential for Gliclazide to pass into breast milk and cause hypoglycemia in the infant.
• Liver - Use with caution in patients with liver impairment; dose adjustment may be necessary to prevent drug accumulation and severe hypoglycemia.
• Kidney - Use with caution in patients with kidney impairment; dose adjustment may be necessary to reduce the risk of drug accumulation and hypoglycemia.
• Lung - Generally not a primary concern for lung conditions. However, severe respiratory insufficiency could indirectly impact glucose regulation.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.